Working for access to quality public healthcare in South Africa since 1998
29 October 2014

Reducing Cervical Cancer

Cervical cancer kills more women in South Africa than any other form of cancer. It is also more prevalent in HIV positive women than in HIV negative women. While the Department of Health has employed relatively good policies, these policies are not very well implemented. Women should be able to a...

8 December 2008

Glaxo’s HPV Vaccine Price Reduction: TAC Urges Caution

At a press conference last month, the Treatment Action Campaign (TAC) called for price deductions on the two Human Papilloma Virus (HPV) vaccines, manufactured by GlaxoSmithKline and Merck. HPV is a common sexually transmitted infection, and some strains of the disease cause cervical cancer. In S...

11 November 2008

TAC hosts press conference on HPV vaccine access with message of support from Annie Lennox

Today, Tuesday 11 November, the Treatment Action Campaign hosted a press conference to draw attention to our recent global call for affordable access to HPV vaccines for developing countries.     You can learn more about our HPV vaccine access campaign by clicking here. The main speakers at to...

28 October 2008

TAC issues global call for affordable access to HPV vaccines in the developing world

TAC has issued the following global call for affordable access to HPV vaccines in non-OECD (developing) countries. Copies of the statement below will be delivered to representatives of Merck and GlaxoSmithKline, the manufactures and patent-holders of the Gardasil© and Ceravix© HPV vaccines , resp...

17 June 2008

Lusikisiki releases it first district newsletter

TAC Lusikisiki has launched the first edition of “Izwi Labantu” (Voice of the People), its quarterly district newsletter. The publication is edited by Tandeka Vinjwa, a Media Literacy Practitioner at TAC’s Lusikisiki office. This edition focuses primarily on rape and gender-based violence to coin...